《大行報告》瑞信下調瑞聲(02018.HK)評級至「中性」 目標價降至18.1元
瑞信發表報告指,由於技術問題,蘋果iPhone的新按鍵設計可能推遲到明年下半年推出,將瑞聲(02018.HK)的評級由「跑嬴大市」下調至「中性」。
該行早前估計,假設iPhone有關產品淨利潤率為10%,將可以產生額外7至9億人民幣淨利潤,將相當於去年9至12%純利。該行稱如果技術問題迅速得到解決,蘋果或仍可能會升級iPhone 15系列,但目前認為將要推遲到2024年。
瑞信將今年至後年每股盈利預測分別下調10%/4%/1%,以反映延遲和產品組合的影響。目標價由20元下調至18.1元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.